Earnings Summary

Takeda Pharmaceutical Company Limited’s revenue jumped 12.75% since last year same period to $1176038Mn in the Q3 2024. On a quarterly growth basis, Takeda Pharmaceutical Company Limited has generated -2.65% fall in its revenue since last 3-months.

Takeda Pharmaceutical Company Limited’s net profit jumped 291.64% since last year same period to $92046Mn in the Q3 2024. On a quarterly growth basis, Takeda Pharmaceutical Company Limited has generated -3.36% fall in its net profits since last 3-months.

Takeda Pharmaceutical Company Limited’s net profit margin jumped 269.98% since last year same period to 7.83% in the Q3 2024. On a quarterly growth basis, Takeda Pharmaceutical Company Limited has generated -0.74% fall in its net profit margins since last 3-months.

Takeda Pharmaceutical Company Limited’s earning per share (EPS) estimates for the current quarter stand at 0.63 - a -99.28% fall from last quarter’s estimates.

Takeda Pharmaceutical Company Limited’s earning per share (EPS) estimates for the current year stand at 0.63.

Takeda Pharmaceutical Company Limited’s earning per share (EPS) jumped 287.55% since last year same period to 29.07 in the Q3 2024. This indicates that the Takeda Pharmaceutical Company Limited has generated 287.55% annual rate of jump in its earning per share (EPS) in the last 4 quarters.